BNP Paribas Financial Markets’s Adagene ADAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.2K Buy
7,900
+4,200
+114% +$15.8K ﹤0.01% 5091
2026
Q1
$14.5K Buy
3,700
+2,000
+118% +$5.79K ﹤0.01% 5155
2025
Q4
$3.21K Buy
1,700
+1,400
+467% +$2.58K ﹤0.01% 5308
2025
Q3
$597 Sell
300
-100
-25% -$205 ﹤0.01% 5297
2025
Q2
$792 Sell
400
-1,300
-76% -$2.24K ﹤0.01% 5173
2025
Q1
$2.62K Sell
1,700
-3,000
-64% -$5.61K ﹤0.01% 4946
2024
Q4
$9.16K Buy
+4,700
New +$11.1K ﹤0.01% 4855

Other funds holding ADAG

BNP Paribas Financial Markets's ADAG Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Adagene (ADAG) stake by 114% in Q2 2026, buying an estimated $15.8K and bringing the position to 7,900 shares worth $33.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5091.

BNP Paribas Financial Markets first reported a position in ADAG in Q4 2024 and has held it in 7 quarters since. 35 funds tracked by Wall St. Rank hold ADAG as of Q2 2026.

  • BNP Paribas Financial Markets held 7,900 shares of Adagene worth $33.2K as of Q2 2026.
  • BNP Paribas Financial Markets bought 4,200 Adagene shares in Q2 2026, an estimated $15.8K.
  • Adagene made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5091 holding.
  • BNP Paribas Financial Markets first reported a position in Adagene in Q4 2024 and has held it in 7 quarters since.
  • 35 funds tracked by Wall St. Rank held Adagene as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.